DK645788A - Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat - Google Patents

Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat

Info

Publication number
DK645788A
DK645788A DK645788A DK645788A DK645788A DK 645788 A DK645788 A DK 645788A DK 645788 A DK645788 A DK 645788A DK 645788 A DK645788 A DK 645788A DK 645788 A DK645788 A DK 645788A
Authority
DK
Denmark
Prior art keywords
preparation
ergolin
derivatives
pharmaceutical
pharmaceutical preparation
Prior art date
Application number
DK645788A
Other languages
Danish (da)
English (en)
Other versions
DK645788D0 (da
Inventor
Metilde Buonamici
Lorenzo Pegrassi
Alessandro Rossi
Sergio Mantegani
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878727236A external-priority patent/GB8727236D0/en
Priority claimed from GB888822424A external-priority patent/GB8822424D0/en
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of DK645788D0 publication Critical patent/DK645788D0/da
Publication of DK645788A publication Critical patent/DK645788A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK645788A 1987-11-20 1988-11-18 Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat DK645788A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878727236A GB8727236D0 (en) 1987-11-20 1987-11-20 Antiparkinson ergoline derivatives
GB888822424A GB8822424D0 (en) 1988-09-23 1988-09-23 Antiparkinson ergoline derivatives

Publications (2)

Publication Number Publication Date
DK645788D0 DK645788D0 (da) 1988-11-18
DK645788A true DK645788A (da) 1989-05-21

Family

ID=26293081

Family Applications (1)

Application Number Title Priority Date Filing Date
DK645788A DK645788A (da) 1987-11-20 1988-11-18 Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat

Country Status (20)

Country Link
US (1) US4847253A (zh)
EP (1) EP0317269B1 (zh)
JP (1) JP2655706B2 (zh)
KR (1) KR890007738A (zh)
CN (1) CN1033182A (zh)
AU (1) AU602268B2 (zh)
CA (1) CA1312015C (zh)
DE (1) DE3868866D1 (zh)
DK (1) DK645788A (zh)
ES (1) ES2032570T3 (zh)
FI (1) FI885346A (zh)
GR (1) GR3004355T3 (zh)
HU (1) HU200557B (zh)
IE (1) IE61612B1 (zh)
IL (1) IL88392A (zh)
MY (1) MY103477A (zh)
NO (1) NO885166L (zh)
NZ (1) NZ227022A (zh)
PH (1) PH24515A (zh)
PT (1) PT89036B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE204278T1 (de) * 1992-12-24 2001-09-15 Pharmacia & Upjohn Spa Serotoninergische ergolin derivate
DE69426062T2 (de) * 1993-08-18 2001-03-22 Alcon Laboratories, Inc. Zusammensetzungen von ergolinderivaten zur behandlung des glaukoms
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
GB9407637D0 (en) 1994-04-18 1994-06-08 Erba Carlo Spa Serotoninergic abeo-ergoline derivatives
GB9603226D0 (en) * 1996-02-15 1996-04-17 Pharmacia Spa Heterocyclyl-ergoline derivatives
US6060483A (en) * 1996-06-27 2000-05-09 Pharmacia & Upjohn S.P.A. Antineurodegenerative ergoline derivatives
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
PT1426049E (pt) * 2002-12-02 2005-09-30 Sanol Arznei Schwarz Gmbh Administracao iontoforetica de rotigotina para o tratamento da doenca de parkinson
EP1547592A1 (en) * 2003-12-23 2005-06-29 Schwarz Pharma Ag Intranasal formulation of rotigotine
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
GB8501078D0 (en) * 1985-01-16 1985-02-20 Erba Farmitalia Piperazin-1-yl-ergo-line derivatives

Also Published As

Publication number Publication date
NZ227022A (en) 1991-01-29
AU602268B2 (en) 1990-10-04
AU2568488A (en) 1989-05-25
FI885346A0 (fi) 1988-11-18
CA1312015C (en) 1992-12-29
FI885346A (fi) 1989-05-21
ES2032570T3 (es) 1993-02-16
GR3004355T3 (zh) 1993-03-31
IL88392A (en) 1992-01-15
JP2655706B2 (ja) 1997-09-24
DE3868866D1 (de) 1992-04-09
CN1033182A (zh) 1989-05-31
DK645788D0 (da) 1988-11-18
HUT48463A (en) 1989-06-28
KR890007738A (ko) 1989-07-05
US4847253A (en) 1989-07-11
MY103477A (en) 1993-06-30
PH24515A (en) 1990-07-18
EP0317269A2 (en) 1989-05-24
IE883453L (en) 1989-05-20
JPH01153689A (ja) 1989-06-15
NO885166L (no) 1989-05-22
IL88392A0 (en) 1989-06-30
HU200557B (en) 1990-07-28
EP0317269B1 (en) 1992-03-04
PT89036A (pt) 1988-12-01
NO885166D0 (no) 1988-11-18
PT89036B (pt) 1993-02-26
EP0317269A3 (en) 1990-05-16
IE61612B1 (en) 1994-11-16

Similar Documents

Publication Publication Date Title
DK263288D0 (da) Farmaceutisk praeparat af cefuroxim-axetil
DK89090D0 (da) Farmaceutisk praeparat
DK100488A (da) Farmaceutisk plaster
DK705488A (da) Farmaceutisk praeparat
DK615988D0 (da) Fremgangsmaade til fremstilling af et afsvovlingsmiddel
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
DK128589D0 (da) Anvendelse af piperidinmethanolderivater til fremstilling af et farmaceutisk praeparat
DK689188A (da) Anvendelse af piperidin-derivater til fremstilling af et farmaceutisk praeparat
DK95489D0 (da) Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel
DK473088D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK473288A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK139388A (da) Farmaceutisk praeparat
DK314988A (da) Fremgangsmaade til fremstilling af 6-deoxyguaninderivater
DK265789D0 (da) Fremstilling af et farmaceutisk praeparat
DK276288A (da) Farmaceutisk praeparat
DK651588D0 (da) Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia
DK143889A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK37589A (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
DK184789A (da) Fremgangsmaade til fremstilling af naphthalenderivater
DK171089A (da) Anvendelse af tetrazolderivater til fremstilling af laegemidler
DK473188D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK285589D0 (da) Anvendelse af oxochinazolinderivater til fremstilling af et laegemiddel mod hyperlipidaemi
DK138888D0 (da) Farmaceutisk praeparat
DK99388D0 (da) Fremgangsmaade til fremstilling af piperazinderivater
DK68790A (da) Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment